Cargando…
Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders”
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688166/ https://www.ncbi.nlm.nih.gov/pubmed/38046314 http://dx.doi.org/10.1021/acsomega.3c08464 |
_version_ | 1785152126623678464 |
---|---|
author | Fiorillo, Bianca Roselli, Rosalinda Finamore, Claudia Biagioli, Michele di Giorgio, Cristina Bordoni, Martina Conflitti, Paolo Marchianò, Silvia Bellini, Rachele Rapacciuolo, Pasquale Cassiano, Chiara Limongelli, Vittorio Sepe, Valentina Catalanotti, Bruno Fiorucci, Stefano Zampella, Angela |
author_facet | Fiorillo, Bianca Roselli, Rosalinda Finamore, Claudia Biagioli, Michele di Giorgio, Cristina Bordoni, Martina Conflitti, Paolo Marchianò, Silvia Bellini, Rachele Rapacciuolo, Pasquale Cassiano, Chiara Limongelli, Vittorio Sepe, Valentina Catalanotti, Bruno Fiorucci, Stefano Zampella, Angela |
author_sort | Fiorillo, Bianca |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10688166 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-106881662023-12-01 Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders” Fiorillo, Bianca Roselli, Rosalinda Finamore, Claudia Biagioli, Michele di Giorgio, Cristina Bordoni, Martina Conflitti, Paolo Marchianò, Silvia Bellini, Rachele Rapacciuolo, Pasquale Cassiano, Chiara Limongelli, Vittorio Sepe, Valentina Catalanotti, Bruno Fiorucci, Stefano Zampella, Angela ACS Omega American Chemical Society 2023-11-16 /pmc/articles/PMC10688166/ /pubmed/38046314 http://dx.doi.org/10.1021/acsomega.3c08464 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Fiorillo, Bianca Roselli, Rosalinda Finamore, Claudia Biagioli, Michele di Giorgio, Cristina Bordoni, Martina Conflitti, Paolo Marchianò, Silvia Bellini, Rachele Rapacciuolo, Pasquale Cassiano, Chiara Limongelli, Vittorio Sepe, Valentina Catalanotti, Bruno Fiorucci, Stefano Zampella, Angela Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders” |
title | Correction to “Discovery
of a Novel Class of
Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment
of IL-17-Mediated Disorders” |
title_full | Correction to “Discovery
of a Novel Class of
Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment
of IL-17-Mediated Disorders” |
title_fullStr | Correction to “Discovery
of a Novel Class of
Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment
of IL-17-Mediated Disorders” |
title_full_unstemmed | Correction to “Discovery
of a Novel Class of
Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment
of IL-17-Mediated Disorders” |
title_short | Correction to “Discovery
of a Novel Class of
Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment
of IL-17-Mediated Disorders” |
title_sort | correction to “discovery
of a novel class of
dual gpbar1 agonists–rorγt inverse agonists for the treatment
of il-17-mediated disorders” |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688166/ https://www.ncbi.nlm.nih.gov/pubmed/38046314 http://dx.doi.org/10.1021/acsomega.3c08464 |
work_keys_str_mv | AT fiorillobianca correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders AT rosellirosalinda correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders AT finamoreclaudia correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders AT biagiolimichele correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders AT digiorgiocristina correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders AT bordonimartina correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders AT conflittipaolo correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders AT marchianosilvia correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders AT bellinirachele correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders AT rapacciuolopasquale correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders AT cassianochiara correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders AT limongellivittorio correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders AT sepevalentina correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders AT catalanottibruno correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders AT fioruccistefano correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders AT zampellaangela correctiontodiscoveryofanovelclassofdualgpbar1agonistsrorgtinverseagonistsforthetreatmentofil17mediateddisorders |